MarketCap
Facebook
X
TelegramAnnual report 2025
added 11-25-2025
Becton, Dickinson and Company General and Administrative Expenses 2011-2025 | BDX
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.28 B | 4.86 B | 4.72 B | 4.71 B | 4.72 B | 4.18 B | 2 M | 4.02 B | 2.92 B | 3 B | 2.56 B | 2.14 B | 2.42 B | 1.92 B | 1.85 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.28 B | 2 M | 3.29 B |
Quarterly General and Administrative Expenses Becton, Dickinson and Company
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.32 B | 1.27 B | 1.32 B | 1.2 B | 1.19 B | 1.21 B | 1.19 B | 1.2 B | 1.19 B | - | 1.15 B | 1.19 B | 1.18 B | - | 1.24 B | 1.15 B | 1.15 B | 3.13 B | 980 M | 1.15 B | 1.12 B | 3.24 B | 1.08 B | 1.12 B | 1.07 B | 2.92 B | 1.09 B | 1.07 B | 773 M | 2.15 B | 719 M | 774 M | 709 M | 2.21 B | 728 M | 709 M | 748 M | 1.81 B | 751 M | 748 M | 544 M | 1.58 B | 528 M | 544 M | 531 M | 1.54 B | 534 M | 531 M | 496 M | 1.44 B | 469 M | 496 M | 482 M | 1.34 B | 468 M | 489 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.24 B | 468 M | 1.13 B |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
2.97 B | $ 19.16 | -1.14 % | $ 9.77 B |  USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 5.42 | -2.52 % | $ 109 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.67 | -4.5 % | $ 28.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 83.57 | -0.26 % | $ 1.88 B | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 6.05 | -2.9 % | $ 276 M | USA |
 |
Alcon
ALC
|
251 M | $ 80.15 | -0.26 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
744 M | $ 131.26 | -1.13 % | $ 7 B | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 177.04 | 0.25 % | $ 5.52 B | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 88.28 | 1.02 % | $ 5.14 B | USA |
 |
ICU Medical
ICUI
|
639 M | $ 147.93 | 0.04 % | $ 3.61 B | USA |
 |
AtriCure
ATRC
|
291 M | $ 40.75 | 1.04 % | $ 1.91 B | USA |
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
27.2 M | $ 4.99 | 0.81 % | $ 27.5 K | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 12.92 | -1.37 % | $ 528 M | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.44 | 0.62 % | $ 182 M | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 82.12 | -0.61 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 116.14 | -0.29 % | $ 5.63 B | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 80.27 | -0.03 % | $ 4.04 B | USA |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.81 | -1.73 % | $ 182 M | USA |
 |
ResMed
RMD
|
739 M | $ 244.18 | -0.28 % | $ 35.7 B | USA |
 |
STERIS plc
STE
|
1.33 B | $ 255.84 | 0.23 % | $ 25.2 B | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 575.67 | -0.37 % | $ 204 B | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 2.1 | -2.56 % | $ 21.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.29 | 1.05 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
8.91 M | $ 4.94 | 0.14 % | $ 51.3 M | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 56.54 | -0.37 % | $ 205 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 21.86 | -0.59 % | $ 3.76 B | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 32.4 M | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.32 | -5.31 % | $ 187 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 39.02 | -1.1 % | $ 128 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 14.42 | 0.14 % | $ 693 M | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 165.64 | -0.34 % | $ 9.23 M | USA |
 |
BioLife Solutions
BLFS
|
40.5 M | $ 24.94 | 0.16 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.81 | -2.76 % | $ 24.2 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 23.64 | 1.24 % | $ 1.16 B | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 122.39 | -0.3 % | $ 5.73 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 274.23 | -0.14 % | $ 20 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 11.27 | -2.21 % | $ 2.29 B | USA |